Akebia Therapeutics
AKBA
#7041
Rank
S$0.53 B
Marketcap
$2.45
Share price
1.68%
Change (1 day)
85.20%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.88

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.86. In 2022 the company made an earnings per share (EPS) of -$0.69 an increase over its 2021 EPS that were of -$2.29.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.8828.68%
2022-$0.69-70%
2021-$2.29-38.63%
2020-$3.7317.37%
2019-$3.182.79%
2018-$3.0931.2%
2017-$2.36-51.39%
2016-$4.8557.89%
2015-$3.07-94.83%
2014-$59.44589.75%
2013-$8.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.07-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.04-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$18.98-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.20 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA